Skip to main content
logo
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
291.37
-1.80 (-0.61%)
At close: Jun 26, 2026, 4:00 PM EDT
291.14
-0.23 (-0.08%)
After-hours: Jun 26, 2026, 6:19 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
38,90252,63930,42424,07829,45120,381
Market Cap Growth
-0.08%73.02%26.36%-18.24%44.51%34.69%
Enterprise Value
38,86351,00929,02622,94428,57918,943
Last Close Price
291.37397.65235.31191.41237.65169.58
PE Ratio
73.76170.67----
Forward PE
34.8060.03----
PS Ratio
9.0714.1713.5313.1728.3924.14
PB Ratio
36.1666.70453.50-109.13-186.1334.65
P/TBV Ratio
36.7567.86447.73--34.15
P/FCF Ratio
60.47113.11-574.04--
P/OCF Ratio
54.42100.44-231.18--
EV/Sales Ratio
9.0713.7312.9112.5527.5522.44
EV/EBITDA Ratio
48.1691.54----
EV/EBIT Ratio
51.67101.70----
EV/FCF Ratio
60.41109.61-547.01--
Debt / Equity Ratio
1.141.5618.69-5.73-8.081.63
Debt / EBITDA Ratio
1.582.29----
Debt / FCF Ratio
1.982.75-31.12--
Net Debt / Equity Ratio
-1.61-2.07-20.845.145.51-2.44
Net Debt / EBITDA Ratio
-2.15-2.9211.634.971.182.17
Net Debt / FCF Ratio
-2.70-3.5032.84-27.031.422.00
Asset Turnover
0.850.810.560.500.290.24
Inventory Turnover
9.868.463.862.851.571.73
Quick Ratio
2.882.512.612.863.163.79
Current Ratio
3.132.762.783.083.514.04
Return on Equity (ROE)
26.93%73.28%362.29%232.40%-526.14%-106.31%
Return on Assets (ROA)
14.67%10.58%-3.23%-7.77%-21.92%-20.12%
Return on Invested Capital (ROIC)
62.41%40.00%-11.36%-28.30%-77.24%-64.87%
Return on Capital Employed (ROCE)
20.66%15.31%-5.98%-10.01%-27.42%-24.57%
Earnings Yield
1.38%0.59%----
FCF Yield
1.65%0.88%-0.17%--
Buyback Yield / Dilution
-6.45%-5.51%-2.20%-2.64%-2.73%-3.01%
Total Shareholder Return
-6.45%-5.51%-2.20%-2.64%-2.73%-3.01%
SEC Filings: 10-K · 10-Q